Inc. (NASDAQ:INCR) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition
The following information is being furnished under Item 2.02 of Form 8-K: Press release by Superior Group of Companies, Inc. (the “Company”) announcing its results of operations for the year ended December 31, 2019. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K.
Item 9.0l. Financial Statements and Exhibits
| 99.1 | Press Release, dated February 20, 2020 |
SUPERIOR GROUP OF COMPANIES, INC. Exhibit
EX-99.1 2 ex_173359.htm EXHIBIT 99.1 ex_173359.htm Exhibit 99.1 A NASDAQ Listed Company: SGC FOR IMMEDIATE RELEASE SUPERIOR GROUP OF COMPANIES,…
To view the full exhibit click here
About Inc. (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.